TI-FOAM Dental Implants: Will This New Surface Coating Have an Impact?

Summary:


OpenCell BioMed's implant system is differentiated by its proprietary surface coating/material TI- FOAM(TM) used as the bone to implant interface enabling dental implant systems greater short and long term stability with a minimally invasive techniques compared to traditional dental implant systems.

Full Article:


If you thought the dental implants market was getting crowded, think again!

This past week, OpenCell BioMed Inc., a medical device designer and manufacturer, announced the development of a new unique line of dental implant products.

OpenCell BioMed's implant system is differentiated by its proprietary surface coating/material TI- FOAM(TM) used as the bone to implant interface enabling dental implant systems greater short and long term stability with a minimally invasive techniques compared to traditional dental implant systems.

Dr. Mislav Pavelic CEO-OpenCell BioMed Inc. says: "We are confident that OpenCell BioMed will be able to capture a significant dental implant market share in a sector that is seeing an erosion of market share from previously dominant players. With the aging population and with a doubling in the last decade of healthcare spending OpenCell BioMed and its proprietary products are uniquely positioned for many years of unprecedented growth."

In case you're wondering about the research surrounding TI-FOAM, OpenCell BioMed, has a few research studies posted on it's website at: http://www.opencellbiomed.com/research.htm

Currently, the University of Sao Paulo Brasil is conducting an In Vivo Dog Study with TI-FOAM implants. The experiment involved 36 implants into 6 dogs – 18 of which had TI-FOAM and 18 without TI-FOAM. OpenCell is currently awaiting results of the specimens from Sao Paulo University.

In addition, to the articles posted at OpenCell's website we did a quick PubMed search and came up with a recent study (Biomaterials. 2008 Jan;29(2):161-71. Epub 2007 Oct 23.Hybrid bone implants: self-assembly of peptide amphiphile nanofibers within porous titanium) where researchers reported on a method to prepare a hybrid bone implant material consisting of a Ti-6Al-4V foam, whose 52% porosity is filled with a peptide amphiphile (PA) nanofiber matrix. These PA nanofibers can be highly bioactive by molecular design, and are used here as a strategy to transform an inert titanium foam into a potentially bioactive implant. The researchers concluded that: "The PA-Ti hybrid strategy could be potentially tailored to initiate mineralization and direct a cellular response from the host tissue into porous implants to form new bone and thereby improve fixation, osteointegration, and long term stability of implants."

Source:

OsseoNews.com Editors